Logo image of NGLB.DE

Anglo American plc (NGLB.DE) Stock Fundamental Analysis

FRA:NGLB - Deutsche Boerse Ag - GB00B1XZS820 - Common Stock - Currency: EUR

26.35  +0.2 (+0.76%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to NGLB. NGLB was compared to 36 industry peers in the Metals & Mining industry. Both the profitability and the financial health of NGLB get a neutral evaluation. Nothing too spectacular is happening here. NGLB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

NGLB had positive earnings in the past year.
NGLB had a positive operating cash flow in the past year.
NGLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years NGLB had a positive operating cash flow.
NGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFNGLB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

1.2 Ratios

The Return On Assets of NGLB (-4.73%) is worse than 82.93% of its industry peers.
NGLB has a Return On Equity of -14.78%. This is amonst the worse of the industry: NGLB underperforms 85.37% of its industry peers.
The Return On Invested Capital of NGLB (6.26%) is better than 63.41% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NGLB is above the industry average of 7.09%.
Industry RankSector Rank
ROA -4.73%
ROE -14.78%
ROIC 6.26%
ROA(3y)0.8%
ROA(5y)3.74%
ROE(3y)0.95%
ROE(5y)8.34%
ROIC(3y)9.27%
ROIC(5y)11.68%
NGLB.DE Yearly ROA, ROE, ROICNGLB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20

1.3 Margins

NGLB has a Operating Margin of 18.13%. This is in the better half of the industry: NGLB outperforms 70.73% of its industry peers.
In the last couple of years the Operating Margin of NGLB has declined.
With a decent Gross Margin value of 45.82%, NGLB is doing good in the industry, outperforming 73.17% of the companies in the same industry.
In the last couple of years the Gross Margin of NGLB has remained more or less at the same level.
Industry RankSector Rank
OM 18.13%
PM (TTM) N/A
GM 45.82%
OM growth 3Y-23.9%
OM growth 5Y-2.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.4%
GM growth 5Y1.14%
NGLB.DE Yearly Profit, Operating, Gross MarginsNGLB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), NGLB is creating some value.
Compared to 1 year ago, NGLB has about the same amount of shares outstanding.
NGLB has less shares outstanding than it did 5 years ago.
The debt/assets ratio for NGLB is higher compared to a year ago.
NGLB.DE Yearly Shares OutstandingNGLB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B
NGLB.DE Yearly Total Debt VS Total AssetsNGLB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

NGLB has an Altman-Z score of 2.18. This is not the best score and indicates that NGLB is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.18, NGLB is in line with its industry, outperforming 58.54% of the companies in the same industry.
NGLB has a debt to FCF ratio of 7.31. This is a slightly negative value and a sign of low solvency as NGLB would need 7.31 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.31, NGLB is in line with its industry, outperforming 56.10% of the companies in the same industry.
A Debt/Equity ratio of 0.78 indicates that NGLB is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.78, NGLB is not doing good in the industry: 75.61% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.31
Altman-Z 2.18
ROIC/WACC0.68
WACC9.19%
NGLB.DE Yearly LT Debt VS Equity VS FCFNGLB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B 20B 25B

2.3 Liquidity

NGLB has a Current Ratio of 1.86. This is a normal value and indicates that NGLB is financially healthy and should not expect problems in meeting its short term obligations.
NGLB has a better Current ratio (1.86) than 63.41% of its industry peers.
NGLB has a Quick Ratio of 1.29. This is a normal value and indicates that NGLB is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.29, NGLB is doing good in the industry, outperforming 75.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.86
Quick Ratio 1.29
NGLB.DE Yearly Current Assets VS Current LiabilitesNGLB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

1

3. Growth

3.1 Past

The earnings per share for NGLB have decreased strongly by -33.33% in the last year.
Measured over the past years, NGLB shows a decrease in Earnings Per Share. The EPS has been decreasing by -9.94% on average per year.
NGLB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -10.97%.
NGLB shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.79% yearly.
EPS 1Y (TTM)-33.33%
EPS 3Y-39.23%
EPS 5Y-9.94%
EPS Q2Q%-47.57%
Revenue 1Y (TTM)-10.97%
Revenue growth 3Y-13.08%
Revenue growth 5Y-1.79%
Sales Q2Q%-15.83%

3.2 Future

NGLB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.65% yearly.
NGLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.87% yearly.
EPS Next Y-13.88%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
EPS Next 5Y4.65%
Revenue Next Year-12.33%
Revenue Next 2Y-7.45%
Revenue Next 3Y-3.09%
Revenue Next 5Y-3.87%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NGLB.DE Yearly Revenue VS EstimatesNGLB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
NGLB.DE Yearly EPS VS EstimatesNGLB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 18.96, the valuation of NGLB can be described as rather expensive.
NGLB's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of NGLB to the average of the S&P500 Index (26.34), we can say NGLB is valued slightly cheaper.
With a Price/Forward Earnings ratio of 22.02, NGLB is valued on the expensive side.
NGLB's Price/Forward Earnings is on the same level as the industry average.
NGLB is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 18.96
Fwd PE 22.02
NGLB.DE Price Earnings VS Forward Price EarningsNGLB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

60.98% of the companies in the same industry are more expensive than NGLB, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, NGLB is valued a bit cheaper than the industry average as 73.17% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 16.29
EV/EBITDA 6.3
NGLB.DE Per share dataNGLB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.11%
EPS Next 3Y11.89%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.90%, NGLB has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.20, NGLB pays a bit more dividend than its industry peers.
NGLB's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

The dividend of NGLB decreases each year by -5.62%.
Dividend Growth(5Y)-5.62%
Div Incr Years0
Div Non Decr Years0
NGLB.DE Yearly Dividends per shareNGLB.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

The earnings of NGLB are negative and hence is the payout ratio. NGLB will probably not be able to sustain this dividend level.
DP-33.44%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
NGLB.DE Yearly Income VS Free CF VS DividendNGLB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B

Anglo American plc

FRA:NGLB (5/30/2025, 7:00:00 PM)

26.35

+0.2 (+0.76%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-31 2025-07-31
Inst Owners68.45%
Inst Owner ChangeN/A
Ins Owners0.1%
Ins Owner ChangeN/A
Market Cap35.25B
Analysts73.33
Price Target29.71 (12.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.67
Dividend Growth(5Y)-5.62%
DP-33.44%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.97%
PT rev (3m)-8.54%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-18.1%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.82%
Valuation
Industry RankSector Rank
PE 18.96
Fwd PE 22.02
P/S 1.49
P/FCF 16.29
P/OCF 5.01
P/B 1.95
P/tB 2.05
EV/EBITDA 6.3
EPS(TTM)1.39
EY5.28%
EPS(NY)1.2
Fwd EY4.54%
FCF(TTM)1.62
FCFY6.14%
OCF(TTM)5.26
OCFY19.97%
SpS17.72
BVpS13.48
TBVpS12.87
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.73%
ROE -14.78%
ROCE 8.89%
ROIC 6.26%
ROICexc 7.34%
ROICexgc 7.49%
OM 18.13%
PM (TTM) N/A
GM 45.82%
FCFM 9.13%
ROA(3y)0.8%
ROA(5y)3.74%
ROE(3y)0.95%
ROE(5y)8.34%
ROIC(3y)9.27%
ROIC(5y)11.68%
ROICexc(3y)10.68%
ROICexc(5y)13.58%
ROICexgc(3y)11.14%
ROICexgc(5y)14.35%
ROCE(3y)13.18%
ROCE(5y)16.62%
ROICexcg growth 3Y-35.05%
ROICexcg growth 5Y-7.67%
ROICexc growth 3Y-34.05%
ROICexc growth 5Y-6.65%
OM growth 3Y-23.9%
OM growth 5Y-2.92%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.4%
GM growth 5Y1.14%
F-Score5
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 7.31
Debt/EBITDA 2.02
Cap/Depr 182.68%
Cap/Sales 20.56%
Interest Coverage 5.81
Cash Conversion 101.04%
Profit Quality N/A
Current Ratio 1.86
Quick Ratio 1.29
Altman-Z 2.18
F-Score5
WACC9.19%
ROIC/WACC0.68
Cap/Depr(3y)221.62%
Cap/Depr(5y)211.97%
Cap/Sales(3y)19.39%
Cap/Sales(5y)18.13%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.33%
EPS 3Y-39.23%
EPS 5Y-9.94%
EPS Q2Q%-47.57%
EPS Next Y-13.88%
EPS Next 2Y7.11%
EPS Next 3Y11.89%
EPS Next 5Y4.65%
Revenue 1Y (TTM)-10.97%
Revenue growth 3Y-13.08%
Revenue growth 5Y-1.79%
Sales Q2Q%-15.83%
Revenue Next Year-12.33%
Revenue Next 2Y-7.45%
Revenue Next 3Y-3.09%
Revenue Next 5Y-3.87%
EBIT growth 1Y-23.96%
EBIT growth 3Y-33.85%
EBIT growth 5Y-4.66%
EBIT Next Year43.63%
EBIT Next 3Y20.8%
EBIT Next 5Y5.96%
FCF growth 1Y411.5%
FCF growth 3Y-38.9%
FCF growth 5Y-3.13%
OCF growth 1Y24.74%
OCF growth 3Y-21.46%
OCF growth 5Y1.12%